Latest News about MRK
Recent news which mentions MRK
From Benzinga
These 2 Dividend ETFs Are a Retiree's Best Friend
December 17, 2021
From Motley Fool
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
December 17, 2021
From Benzinga
Why This Once-Promising HIV Candidate Could Be in Trouble
December 17, 2021
Tickers
MRK
From Motley Fool
Is Merck's Dig at Pfizer's COVID-19 Pill Justified?
December 17, 2021
From Motley Fool
3 COVID Stocks That Will Pay You Rich Dividends in 2022
December 16, 2021
From Motley Fool
2 Dirt-Cheap Growth Stocks Trading Near Their 52-Week Lows
December 16, 2021
From Motley Fool
EU meets to discuss response to omicron variant as France restricts travel from UK, and CDC panel to discuss rare side effect from J&J vaccine
December 16, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
Some ETFs mix investing with charities — should you?
December 16, 2021
From MarketWatch
Is It Time to Buy the 8 Worst-Performing Dividend Stocks of 2021?
December 15, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
December 14, 2021
From Benzinga
From Motley Fool
The Use of High Pressure is Transforming the Nutraceuticals (CBD), Food & Beverage, Healthcare, and other Billion-Dollar Markets
December 14, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021
December 13, 2021
From Benzinga
Merck Raises $1 Billion Via Inaugural Sustainability Bond
December 13, 2021
Tickers
MRK
From Benzinga
2 Top Biotech Stocks To Buy Right Now
December 13, 2021
From Motley Fool
Why an FDA Panel Had Concerns About Merck's COVID-19 Pill
December 10, 2021
From Motley Fool
Here’s a list of favored dividend stocks with room to pay more for investors worried about 2022
December 10, 2021
From MarketWatch
Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?
December 10, 2021
From Motley Fool
Why You Should Buy Moderna Stock at Every Dip
December 10, 2021
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Looking for the ‘hidden value’ unearths GM and other stock gems for this fund manager
December 09, 2021
From MarketWatch
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
Pfizer, Merck COVID-19 Pills US Launch In This Month; Other Countries Will Have to Wait: WSJ
December 07, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.